§ 23-25.6-5. Redistribution of donated medications.
(a) A redistributor may dispense prescription drugs to eligible persons as long as they
abide by the provisions of this chapter.
(b) A redistributor may repackage drugs prior to redistribution. Repackaged drugs shall
be labeled thoroughly and labels shall include the drug name, expiration date, and
kept separately from other drugs until brought up for inspection. If multiple drugs
are packaged together, the closest expiration date shall be used pursuant to the requirements
contained in § 23-25.6-4(b).
(c) A r
Free access — add to your briefcase to read the full text and ask questions with AI
§ 23-25.6-5. Redistribution of donated medications.
(a) A redistributor may dispense prescription drugs to eligible persons as long as they
abide by the provisions of this chapter.
(b) A redistributor may repackage drugs prior to redistribution. Repackaged drugs shall
be labeled thoroughly and labels shall include the drug name, expiration date, and
kept separately from other drugs until brought up for inspection. If multiple drugs
are packaged together, the closest expiration date shall be used pursuant to the requirements
contained in § 23-25.6-4(b).
(c) A redistributor's compensation from an institution will not constitute the resale
of drugs. The distributor shall make a record of that charge and provide it upon request
to the supervising government agency. This sale price shall reflect an incentive to
offer the drugs at a price that is affordable and reasonable for people who do not
have the means to pay for the drugs at market price. The price incurred by the patient
shall not exceed the usual and customary dispensing fee determined by the this state's
Medicaid program.
(d) Donated drugs that cannot be utilized by the redistributor shall be destroyed through
lawful methods, or transferred to a returns processor. Redistributors shall keep a
record of disposed drugs, the quantity of drug, its name, and strength.
(e) An authorized redistributor of drugs shall store the drugs legally, separate from
other non-donated drugs, and shall meet the requirements of the United States Pharmacopoeia
(USP) standards. The drugs shall be stored in a way that does not impair the quality
and safety of the drug. The drug shall be stored legally according to the methods
described in this chapter. The facilities and storage shall be subject to investigation
and approval from the department of health or a third party approved by the department
of health. All records required pursuant to the provisions of this chapter shall be
retained in physical or electronic format for a period of two (2) years. The drugs
shall be labeled properly with a serial number or other effective label. Redistributors
shall keep records by either electronic or non-electronic means for the full two (2)
years.